Abstract Topics

Plenary 

  • New research approaches in the study of infectious diseases in children
  • The future of vaccines (is now)
  • One health – The human – Animal interface

Symposium

  • Paediatric sepsis
  • Pediatric infectious disease in unstable settings
  • Perinatal infections – The mother – Infant pair
  • Vaccine challenges
  • Novelties in diagnostic microbiology in pediatrics
  • Children on the move – Practical aspects on travel medicine and migrant health
  • Congenital CMV infection
  • Influenza prevention and children
  • Healthcare associated infections in children
  • Infections which define immune responses – Or the other way around?
  • Prevention of meningococcal disease – the way forward
  • Is it infection or inflammation?
  • Infections in paediatric oncology and HSCT patients

MTE

  • Complicated pneumonia (diagnostic and treatment approaches)
  • Endocarditis in children
  • Lyme disease – Diagnosis and management
  • Invasive fungal infections in immunocompromised children
  • Prevention of vertical transmission of HIV
  • Tuberculosis – Still with us
  • Diagnostic and treatment dilemmas in acute encephalitis
  • How to do an audit on the use of antibiotics
  • Diagnosis and management of osteomyelitis in children
  • CMV infection in the neonate
  • Diagnostic considerations in the frequently sick child
  • Kawasaki disease dilemmas
  • Diagnostic approaches in paediatric infectious diseases (microbiology vs. host response)
  • Management of ventriculoperitoneal shunt infections in children
  • Mycoplasma pneumonia
  • Vaccine Acceptance

General Topics

  • Antimicrobials, diagnostics and infection control
    • Antimicrobials: resistance and pharmacology
    • Microbiological diagnostic tools
    • Healthcare-associated and surgical infections
  • Public health and epidemiology
    • Population studies and surveillance
    • Modelling studies
  • Vaccines
    • Vaccine development (phase 1-2) –  viral
    • Vaccine development (phase 1-2)  – bacterial and all non-viral
    • Vaccine efficacy (phase 3) and effectiveness – viral
    • Vaccine efficacy (phase 3) and effectiveness – bacterial and all non-viral
    • Vaccine safety (post licensure)
  • Immunology & compromised host
    • Host-pathogen interaction
    • Host response diagnostics and imaging
    • Severe/systemic fungal infections
    • Infections in immunocompromised patients
  • Global health
    • Zoonosis, vector-borne and emerging infections
    • Tropical/parasite infections & travel medicine
    • Refugees and migrants
  • Infections in early life
    • Congenital and perinatal infections
  • Respiratory infections
    • Upper respiratory infections and carriage studies
    • Lower respiratory infections and pneumonia
  • Non-respiratory infections
    • Gastrointestinal infections
    • Urogenital infections
    • CNS infections
    • Systemic and multi-organ infections
  • Mycobacteria and retroviruses
    •  Tuberculosis and other mycobacterial infections
    • HIV/AIDS
  •  Others
Print Friendly, PDF & Email